Tropomyosin Receptor Kinases Inhibitors
- Name
- Tropomyosin Receptor Kinases Inhibitors
- Accession Number
- DBCAT005471
- Description
Not Available
- Drugs
Drug Drug Description Larotrectinib A kinase inhibitor used to treat solid tumors with neurotrophic receptor tyrosine kinase gene fusion, are metastatic, high risk for surgery, or have no alternative treatments. - Drugs & Drug Targets